These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


512 related items for PubMed ID: 26895380

  • 1. Upregulated WDR26 serves as a scaffold to coordinate PI3K/ AKT pathway-driven breast cancer cell growth, migration, and invasion.
    Ye Y, Tang X, Sun Z, Chen S.
    Oncotarget; 2016 Apr 05; 7(14):17854-69. PubMed ID: 26895380
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
    Li F, Yin X, Luo X, Li HY, Su X, Wang XY, Chen L, Zheng K, Ren GS.
    Cell Signal; 2013 Jun 05; 25(6):1413-22. PubMed ID: 23524337
    [Abstract] [Full Text] [Related]

  • 4. MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.
    Li N, Miao Y, Shan Y, Liu B, Li Y, Zhao L, Jia L.
    Cell Death Dis; 2017 May 18; 8(5):e2796. PubMed ID: 28518139
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Activated-PAK4 predicts worse prognosis in breast cancer and promotes tumorigenesis through activation of PI3K/AKT signaling.
    He LF, Xu HW, Chen M, Xian ZR, Wen XF, Chen MN, Du CW, Huang WH, Wu JD, Zhang GJ.
    Oncotarget; 2017 Mar 14; 8(11):17573-17585. PubMed ID: 28407679
    [Abstract] [Full Text] [Related]

  • 13. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
    Chun J, Kim YS.
    Chem Biol Interact; 2013 Oct 05; 205(3):212-21. PubMed ID: 23867902
    [Abstract] [Full Text] [Related]

  • 14. Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes.
    Xue G, Restuccia DF, Lan Q, Hynx D, Dirnhofer S, Hess D, Rüegg C, Hemmings BA.
    Cancer Discov; 2012 Mar 05; 2(3):248-59. PubMed ID: 22585995
    [Abstract] [Full Text] [Related]

  • 15. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY, Jiao DM, Wu YQ, Chen J, Wang J, Tang XL, Mou H, Hu HZ, Song J, Yan J, Wu LJ, Chen J, Wang Z.
    Oncotarget; 2016 Apr 05; 7(14):18247-61. PubMed ID: 26919096
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Arachidonic acid promotes migration and invasion through a PI3K/Akt-dependent pathway in MDA-MB-231 breast cancer cells.
    Villegas-Comonfort S, Castillo-Sanchez R, Serna-Marquez N, Cortes-Reynosa P, Salazar EP.
    Prostaglandins Leukot Essent Fatty Acids; 2014 May 05; 90(5):169-77. PubMed ID: 24565443
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.